IDEAYA Biosciences Inc. logo

IDEAYA Biosciences Inc.

IDYA | NASDAQ
Chart Builder DCF Calculator
$39.75
+$0.89 (+2.29%)
Sep 22, 2026, 1:59 PM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
8.86M 6.56M 10.88M 207.83M n/a n/a 7M n/a n/a n/a 3.92M 8.04M 3.54M 7.88M 4.02M 29.7M 5.85M 11.36M 2.96M 8.98M 8.76M 7.25M
Cost of Revenue
n/a 1.14M 86.6M 82.99M 74.23M 70.89M 643K 1.01M 1.1M 1.08M 1.02M 986K 998K 960K 558K 925K 1.2M 464K 425K 15.5M 14.98M 11.57M
Gross Profit
8.86M 5.42M -75.72M 124.84M -74.23M -70.89M 6.36M -1.01M -1.1M -1.08M 2.9M 7.05M 2.55M 6.92M 3.46M 28.77M 4.65M 10.9M 2.54M -6.53M -6.22M -4.32M
Operating Income
-122.29M -108.54M -94.57M 108.45M -88.81M -84.39M -144.14M -66.89M -64.93M -51.02M -41.92M -33.53M -32.71M -26.28M -26.44M 660K -22.5M -14.22M -18.37M -11.71M -11.05M -9.14M
Interest Income
n/a 10.01M 11.3M 10.79M 11.32M 12.21M 13.83M 15.07M 12.16M 11.45M 7.96M 6.09M 4.78M 2.64M 2.24M 955K 443K 207K 157K 131K 104K 114K
Pretax Income
-112.45M -98.54M -83.27M 119.24M -77.49M -71.41M -130.31M -51.82M -52.77M -39.57M -33.96M -27.44M -27.93M -23.64M -24.2M 1.62M -22.06M -14.01M -18.21M -11.58M -10.95M -9.02M
Net Income
-112.45M -98.54M -83.27M 119.24M -77.49M -71.41M -130.31M -51.82M -52.77M -39.57M -33.96M -27.44M -27.93M -23.64M -24.2M 1.62M -22.06M -14.01M -18.21M -11.58M -10.95M -9.02M
Selling & General & Admin
22.46M 19.38M 18.85M 16.39M 14.58M 13.5M 10.31M 8.73M 9.3M 7.13M 6.04M 6.88M 6.08M 5.34M 5.19M 5.74M 4.35M 5.46M 4.8M 4.69M 4.43M 4.43M
Research & Development
108.69M 95.73M 86.6M 82.99M 74.23M 70.89M 140.18M 57.15M 54.53M 42.81M 38.77M 33.7M 29.18M 27.86M 24.71M 22.37M 22.8M 19.66M 16.11M 15.5M 14.98M 11.57M
Other Expenses
n/a -1.14M -86.6M -82.99M -74.23M -70.89M n/a n/a n/a n/a n/a n/a n/a n/a -1K n/a n/a n/a n/a -15M -14.58M -11.18M
Operating Expenses
131.15M 113.96M 18.85M 16.39M 14.58M 13.5M 150.5M 65.88M 63.83M 49.94M 44.81M 40.58M 35.26M 33.2M 29.91M 28.11M 27.15M 25.12M 20.91M 5.19M 4.83M 4.82M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
131.15M 115.1M 105.45M 99.38M 88.81M 84.39M 151.14M 66.89M 64.93M 51.02M 45.84M 41.56M 36.25M 34.16M 30.47M 29.04M 28.35M 25.58M 21.33M 20.69M 19.81M 16.38M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
92.06M 88.7M 88.58M 89.66M 88.47M 88.36M 87.34M 86.19M 77.96M 75.11M 65.25M 60M 56.25M 48.37M 48.13M 40.3M 38.66M 38.59M 38.36M 37.36M 32.85M 31.76M
Shares Outstanding (Diluted)
92.06M 88.7M 88.58M 89.69M 88.47M 88.36M 87.34M 86.19M 77.96M 75.11M 65.25M 60M 56.25M 48.37M 48.13M 41.11M 38.66M 38.59M 38.5M 37.77M 32.85M 31.76M
EPS (Basic)
-1.22 -1.11 -0.94 1.35 -0.88 -0.82 -1.49 -0.60 -0.68 -0.53 -0.52 -0.46 -0.50 -0.41 -0.46 0.06 -0.56 -0.47 -0.47 -0.31 -0.33 -0.28
EPS (Diluted)
-1.22 -1.11 -0.94 1.33 -0.88 -0.82 -1.49 -0.60 -0.68 -0.53 -0.52 -0.46 -0.50 -0.41 -0.46 0.06 -0.56 -0.47 -0.47 -0.31 -0.33 -0.28
EBITDA
-110.19M -97.4M -82.08M 120.27M -76.26M -70.27M -129.67M -50.81M -51.68M -38.49M -32.93M -26.45M -26.93M -22.68M -23.64M 2.54M -20.85M -13.55M -17.79M -11.08M -10.55M -8.64M
EBIT
-112.45M -98.54M -83.27M 119.24M -77.49M -71.41M -130.31M -51.82M -52.77M -39.57M -33.96M -27.44M -27.93M -23.64M -24.2M 1.62M -22.06M -14.01M -18.21M -11.58M -10.95M -9.02M
Depreciation & Amortization
2.26M 1.14M 1.2M 1.03M 1.23M 1.13M 643K 1.01M 1.1M 1.08M 1.02M 986K 998K 960K 558K 925K 1.2M 464K 425K 500K 400K 382K

© 2026 bestshares.com. All rights reserved.